Effects of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on Epirubicin's Anticancer Activity
Author Information
Author(s): Chan Szu-Erh, Lai Hung-Wen, Su Chin-Cheng, Kuo Shou-Jen, Chien Su-Yu, Lin Hui-Yi, Chen Dar-Ren
Primary Institution: Changhua Christian Hospital
Hypothesis
Does the supplementation of STS or Tan IIA affect the anticancer activity of epirubicin?
Conclusion
Tan IIA enhances the anticancer effects of epirubicin, while STS reduces its effectiveness.
Supporting Evidence
- Tanshinone IIA inhibited BT-20 cell growth and induced apoptosis in a dose-dependent manner.
- STS decreased the epirubicin-induced cytotoxicity and apoptosis in BT-20 cells.
- The combination of STS with epirubicin resulted in an antagonistic effect.
- The combination of Tan IIA with epirubicin resulted in a more complex interaction, sometimes synergistic.
Takeaway
This study looked at how two compounds from a traditional medicine affect a cancer drug. One compound helps the cancer drug work better, while the other makes it less effective.
Methodology
The study used BT-20 breast cancer cells to evaluate the effects of Tan IIA and STS on cell viability, apoptosis, and epirubicin uptake.
Limitations
The study was limited to in vitro experiments and did not include in vivo validation.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website